Vendor review
Bfflist AMO reviews
Bfflist AMO reviews from 74 independent lab tests (Retatrutide, Tirzepatide and Cagrilintide): grade A, purity and fill accuracy. Is Bfflist AMO legit? See what its vials showed.
What the lab tests show
74 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | Tirzepatide | 100 % | 31.1513 mg of 30 mg (4 %) | Pass | View |
| Jul 15, 2026 | Retatrutide | 99.8 % | 12.3 mg of 12 mg (3 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 9.59 mg of 20 mg (-52 %) | Pass | View |
| Apr 21, 2026 | Retatrutide | 99.8 % | 10.6 mg of 12 mg (-12 %) | Pass | View |
| Mar 29, 2026 | Retatrutide | 99.9 % | 56 mg of 60 mg (-7 %) | Pass | View |
| Mar 21, 2026 | Cagrilintide | 99.8 % | 9.3 mg of 10 mg (-7 %) | Pass | View |
| Mar 18, 2026 | Cagrilintide | 99.9 % | 2.55 mg of 10 mg (-75 %) | Pass | View |
| Feb 18, 2026 | Retatrutide | 99.9 % | 29.6 mg of 30 mg (-1 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 98.85 % | 29.9 mg of 30 mg (0 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 98.9 % | 59.9 mg of 60 mg (0 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 98.24 % | 30.1 mg of 30 mg (0 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.9 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| Feb 16, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 16, 2026 | Retatrutide | 99.9 % | 4.96 mg of 5 mg (-1 %) | Pass | View |
| Feb 15, 2026 | Retatrutide | 99.8 % | 25.6 mg of 30 mg (-15 %) | Pass | View |
| Feb 13, 2026 | Retatrutide | 99.9 % | 29.5 mg of 30 mg (-2 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 23.6 mg of 24 mg (-2 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.69 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
| Feb 4, 2026 | Retatrutide | 99.8 % | 24.9 mg of 30 mg (-17 %) | Pass | View |
| Feb 2, 2026 | Cagrilintide | 99.16 % | 9.43 mg of 10 mg (-6 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.71 % | 20 mg of 20 mg (0 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.67 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.46 % | 12.8 mg of 12 mg (7 %) | Pass | View |
| Jan 29, 2026 | Tirzepatide | 99.9 % | 28.1 mg of 30 mg (-6 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.9 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 29.9 mg of 30 mg (0 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.9 % | 26.7 mg of 30 mg (-11 %) | Pass | View |
| Jan 22, 2026 | Cagrilintide | 99.8 % | 2.6 mg of 5 mg (-48 %) | Pass | View |
| Jan 22, 2026 | Retatrutide | 99.9 % | 12.1 mg of 15 mg (-19 %) | Pass | View |
| Jan 22, 2026 | Retatrutide | 99.8 % | 11.4 mg of 15 mg (-24 %) | Pass | View |
| Jan 22, 2026 | Retatrutide | 99 % | 56.7 mg of 60 mg (-5 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.95 % | 11.3 mg of 12 mg (-6 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.9 % | 18.8 mg of 20 mg (-6 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.7 % | 9.2 mg of 10 mg (-8 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.85 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.8 % | 59.8 mg of 50 mg (20 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.8 % | 42.9 mg of 40 mg (7 %) | Pass | View |
| Jan 1, 2026 | Cagrilintide | 99.4 % | 4.5 mg of 5 mg (-10 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.8 % | 48.2 mg of 60 mg (-20 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.9 % | 9.18 mg of 10 mg (-8 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.95 % | 20 mg of 20 mg (0 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.95 % | 4.65 mg of 5 mg (-7 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.8 % | 11.9 mg of 15 mg (-21 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 26.9 mg of 30 mg (-10 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.9 % | 24.7 mg of 20 mg (24 %) | Pass | View |
| Dec 10, 2025 | Cagrilintide | 98.6 % | 1.1 mg of 5 mg (-78 %) | Pass | View |
| Dec 6, 2025 | Retatrutide | 99.95 % | 9.35 mg of 10 mg (-7 %) | Pass | View |
| Dec 6, 2025 | Tirzepatide | 99.81 % | 28.3 mg of 30 mg (-6 %) | Pass | View |
| Nov 25, 2025 | Tirzepatide | 99.95 % | 62.5 mg of 60 mg (4 %) | Pass | View |
| Nov 25, 2025 | Semaglutide | 99.46 % | 9.52 mg of 10 mg (-5 %) | Pass | View |
| Nov 23, 2025 | Retatrutide | 99.9 % | 26.5 mg of 30 mg (-12 %) | Pass | View |
| Nov 18, 2025 | Retatrutide | 99.81 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| Nov 6, 2025 | Retatrutide | 99.74 % | 13.1 mg of 15 mg (-13 %) | Pass | View |
| Nov 3, 2025 | Retatrutide | 99.9 % | 8.9 mg of 10 mg (-11 %) | Pass | View |
| Oct 29, 2025 | Retatrutide | 99.95 % | 28.2 mg of 30 mg (-6 %) | Pass | View |
| Oct 29, 2025 | Tirzepatide | 99.49 % | 27 mg of 30 mg (-10 %) | Pass | View |
| Oct 24, 2025 | Retatrutide | 99.8 % | 8 mg of 15 mg (-47 %) | Pass | View |
| Oct 23, 2025 | Retatrutide | 99.95 % | 17.7 mg of 20 mg (-12 %) | Pass | View |
| Oct 14, 2025 | Retatrutide | 99.8 % | 36 mg of 10 mg (260 %) | Pass | View |
| Oct 7, 2025 | Retatrutide | 99.9 % | 30.2 mg of 15 mg (101 %) | Pass | View |
What Bfflist AMO sells
No current listings on record.
About Bfflist AMO
Finnrick has tested 74 samples from Bfflist AMO across 4 products.